May 11, 2024
Investors

ROSEN, A LONGSTANDING LAW FIRM, Encourages Thoughtworks

NEW YORK, May 05, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Thoughtworks Holding, Inc. (NASDAQ: TWKS) resulting from allegations that Thoughtworks may have issued materially misleading business information to the investing public. SO WHAT: If you purchased

Read More
Investors

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages HireRight

NEW YORK, April 21, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of HireRight Holdings Corporation (NYSE: HRT) pursuant and/or traceable to the registration statement and prospectus (collectively, the “Offering Documents”) issued in connection with HireRight’s October 2021 initial public offering (the “IPO”), of the

Read More
Investors

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages

NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hut 8 Corp. (NASDAQ: HUT) between November 9, 2023 and January 18, 2024, both dates inclusive (the “Class Period”), of the important April 8, 2024 lead plaintiff deadline. SO WHAT: If you

Read More
Investors

ROSEN, A LEADING LAW FIRM, Encourages InMode Ltd. Investors

NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of InMode Ltd. (NASDAQ: INMD) between June 4, 2021 and October 12, 2023, both dates inclusive (the “Class Period”), of the important April 15, 2024 lead plaintiff deadline. SO WHAT: If you

Read More
Investors

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages

NEW YORK, March 10, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GrafTech International Ltd. (NYSE: EAF) between February 8, 2019 and August 3, 2023, both dates inclusive (the “Class Period”), of the important March 25, 2024 lead plaintiff deadline. SO WHAT: If

Read More
Investors

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Hywin

NEW YORK, March 10, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Hywin Holdings Ltd. (NASDAQ: HYW) resulting from allegations that Hywin Holdings may have issued materially misleading business information to the investing public. SO WHAT: If you

Read More
Investors

GNRC SHAREHOLDER ALERT: ROSEN, LEADING INVESTOR COUNSEL,

NEW YORK, Dec. 30, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Generac Holdings Inc. (NYSE: GNRC) between May 3, 2023 and August 3, 2023, both dates inclusive (the “Class Period”), of the important January 22, 2024 lead plaintiff deadline. SO WHAT: If you

Read More
Investors

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Expensify, Inc.

NEW YORK, Dec. 30, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Expensify, Inc. (NASDAQ: EXFY) pursuant and/or traceable to the Offering Documents issued in connection with the Company’s Initial Public Offering conducted on or about November 11, 2021 (“IPO” or “Offering”), of

Read More
Investors

XPOF LOSS ALERT: ROSEN, NATIONALLY REGARDED INVESTOR

NEW YORK, Dec. 25, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Xponential Fitness, Inc. (NYSE: XPOF) resulting from allegations that Xponential Fitness may have issued materially misleading business information to the investing public. SO WHAT: If you purchased

Read More
Investors

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Brainstorm Cell

NEW YORK, Dec. 25, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) between August 15, 2022 and September 27, 2023, both dates inclusive (the “Class Period”), of the important January 2, 2024 lead plaintiff deadline in the securities

Read More